Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Do not use this drug if you or a family member has had: Medullary Thyroid Carcinoma (MTC) Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) FDA Adverse Event Reporting To report side effects, visit www.fda.gov/medwatch or call 1-800-FDA-1088
A high GSTM3 expression was associated with worse survival among bladder cancer patients (24)
Quick Answer: Yes, military members can take GLP-1 medications, but active-duty personnel must obtain a prescription through a military provider or a TRICARE-authorized channel and may require a medical waiver or commander notification to ensure the treatment does not interfere with deployability
IGlarLixi is a fixed-ratio combination of insulin glargine and lixisenatide, containing 100 U/mL of glargine and 33 lg/mL of lixisenatide in a 3-mL prefilled injection pen
